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Objectives+ The purpose of this investigation was to determine 
whether myocardiai blood flow and How reserve, based on quan- 
titative measurements derived from positron emission tomo- 
graphic (PET) imagiug, would be globally impaired in ehild~n 
with a previous history of Kawasaki disease asld normal epicardial 
coronary arteries. 
&ckgrurtnd. Kawasaki disease is an acute inflammatory pro- 
cess of the arterial walis that results in panvasralitis in early 
childhood. Children with a history of Kawasaki disease and 
nurmrl epicaxEd romuarf 3rtczks xx praiow!y considered to 
have normal coronary flow reserve. However, recent studies have 
reported exe&se-induced regional perfusion abnormalities on 
single-photon positron emission tomographic (SPECT) imaging. 
Melhods. We assessed myocardial Mood Row and flow reserve 
at rest and during adenosine stress with nitrogen-13 ammonia 
and BET in 10 childrer with a history of Kawasaki disease and in 
10 heakhy young ad& volunteers. All children bad acute Ka- 
wasaki disease 4 to 15 years before the PET study, None of the 
children had epicardial coronary artery abnormalities at the acute 
stage of the disease or during PoSlow-up, as assessed by echocar- 
diograpby. 
Kawasaki disease is an acute inflammatory process of early 
childhood that frequently affects the coronarjr arteries and may 
result in demonstrable coronary Lesions during the acute phase 
of the illness. Coronary arteq aneurysms develop in -5% to 
10% of children with the disease and may lead to infarction; 
sudden death or chronic coronary artery insufficiency (I). Until 
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Resuits~ Rest blood flows normalized tn the rate-pressure 
product, au index of cardiac work, were similar in both the 
patieuts with Kawasaki disease and healthy ad& volunteers 
(82 ST 14 vs. 77 zt I6 m&B?0 g per rnin [mean k SU], p = NS). 
However, hyperemic blood flaws were significantly lower in the 
patients with Kawasaki diserse than in the control subjects 
(263 I: 64 vs. 340 f 57 ml/PO0 g per min, p = ON). .k a result, 
estimates af myocardial flow reserve were lower in the patients 
with Kawasaki disease than in the healthy young adult vobmteers 
(3.2 k 0.7 vs. 4.6 k 0.9, p = O&03). In addition, total corouahy 
resistance was higher in the patieats with Kawasaki disease than 
in the healthy adult volunteers (33 k 11 vs. 24 9 5 mm &/ml per 
g per min, p = MM). Quantitative analysis of perfusion images 
demonstrated no evidence of regional pesfusion abnormalities. 
CORC~~ORS. Children with a previous history of Kawasaki 
disease and normal epicardial tornanry arteries &dbit normal 
rest myocardial blood flows but reduced byperemis flows and flow 
reserve. The abnormal hyperemie blood flows and Row reserve 
suggest an impaired vasodilatoly capacity, possibly due to resid- 
ual damage of the coronary microcirculation, 
(J Am Go/l GardiolI996;28:757- 62) 
recently, children with a previous history of Kawasaki disease 
but no detectable coronaq abnormalities were not considered 
to be at risk for myocardial &hernia (2). However, recent 
studies have reported the presence of reversible perfusion 
abnormalities, as assessed by technetium-99m or thallium-201 
single-photon emission computed tomographic (SPECT) im- 
aging, in asymptomatic children with a previous history nf 
Kawasaki disease and normai coronary arteries (3,4). The 
clinical significance of these reversible perfusion defects in 
myocardial territories supplied by normal epicardial coronary 
arteries remains unknown. Pathophysiologically, they may 
indicate the presence of lumen narrowing or thickening, or 
both, of the wall in the croraaary microvasculature as a result of 
a previous inflammatory process. What remains intriguing, 
however, is that although Kawasaki disease typically induces a 
d&se coronary vasculitis, most previous reports have shnwn 
only regional perfnsion abnormalities (3,4). Whether :he alter- 
ations in myocardial perfusion seen in asymptomatic children 
who have presumably recovered from iiawasaki disease and 
Positron emission tomography (PET) is an imaging modal- 
ity that allows noninvasive quantification of regional myocar- 
dial blood Row. Ou~:nti~ca~5k2 of m~~cartlial bIood flow and 
ihv rescm using nitrogen-13 (N-13) mxnoni~t :md PET has 
been extensively validated in animals and ff’,lmanc (S-7:. 
Furthermore, this technique has been used successfuIly hi 
diag~los~ng coronary artery disease (&St), assessing the physio 
logic significance of coronary stenosis (10,ll) and evaluatiiig 
the results of intentcntions such as coronary artery revascular- 
ization (12,13). 
This prospective study tested the hypothesis that myocar- 
dial blood f,ow and flow reserve, based on quantitative mea- 
surements derived from N-13 ammonia and PET imaging, 
would be globally impaired in children with a previous history 
of Kawasaki disease and normal coronary zt&es. 
Study graup. The study group included 20 subjects: 10 
children (8 male, 2 female; mean [tSD] age 12 t 3 years, 
range 7 to 16) with a previous history of Kawasaki disease and 
10 healthy young adult volunteers (7 male, 3 female; mean age 
26 t 6 years, range 20 to 35) with no evidence of cardiovas- 
cular disease based on the absence of symptoms and risk 
factors, a normal rest electrocardiogram (ECG) and a normal 
submaximal treadmill test. The patients with Kawasaki disease 
were selected from a group of 21 children >7 years old ai the 
time of testing (to avoid sedation and to facilitate the blood 
flow measurements), who had been previously diagnosed with 
Kawasaki disease based on established clinical criteria and who 
were knowo to have normal epicardial coronary arteries as 
assessed by echocardiography. Of these 27 patients, 10 agreed 
to participate in this study and comprised our study group. 
Kawasaki disease was diagnosed 4 to 15 years (mean 8 2 4) 
before the PET study. The mean age at the time of presenta- 
tion with acute Kawasaki disease was 4 +- 2 yer;rs. The 
treatment of the acute illness consisted of aspirin in five 
patients and intravenous gamma globulin plus aspirin in the 
remaining five patients. None of the patients with Kawasaki 
disease had aneurysmal formation at the time of acute illness 
or during follow-up, as assessed by echocardiography. Seven of 
the 10 patients studied had reversible exercise stress-induced 
defects on myocardial perfusion SPECT imaging. AI1 subjects 
had a normal rest ECG during all follow-up studies. The study 
protocol was approved by the Institutional Review Board and 
the Radiation Safety Committee of the Children’s Hospital of 
Michigan. All parents or legal guardians gave written informed 
consent to the study. 
Positron emission tomography. All subjects refrained from 
consuming caffeinated beverages or theophylline-containing 
medications for 24 h before the PET study. Myocardial blood 
flow at rest and after intravenous administration of adenosine 
Imaging protocol. A 15-min transmission scan was ac- 
quired for correction of photon attenuation. Beginning with 
the intravenous bolus administration of N-13 ammonia 
(0.286 mCi/kg)~ serial images were acquired for 20 min (12 frames 
of 10 s each, 4 frames of 15 s, 4 frames of 30 ;, and 3 frames of 
300 s). Fifty minutes later, after physical decay of N-13 ammonia, 
adenosine (0.14 mgikg body weight per min) was infused over 
6 min. Three minutes after the onset of the adenosine infusion, 
a second dose of N-13 ammonia (0.286 mCi/k$ was injected, 
and the images were recorded in the same acquisition se- 
quence. Patient motion was minimized by fastening a Velcro 
strap across the patient’s chest. Heart rate, cuff blood presstire 
(Dynamap, Critikon Inc.) and a 1Zlead ECG were monitored 
zmtinuously throughout the procedure and recorded at base- 
line, every minute during the adenosine infusion and for 5 min 
af%r termination of adenosine infusion. 
Image analysis. The 47 transaxial tomographic slices were 
reoriented into 12 short-axis and 6 vertical long-axis slices of 
the heart using a SUN SPARC IPX workstation (SUN Micro- 
systems Inc.). 
Quantification of myocardiai blood flow. To quantify re- 
gional myocardial blood flows at rest and during hyperenzia: 12 
sectorial regions of interest (ROIs) in four midventricular 
short-axis slices were automatically defined. Assignmeilt of 
sectorial ROIs is based on radial activity profiles with a blood 
volume fraction of 50% to 60% (14), which allows incorpora- 
tion of in-plane partial volume effects and blood-to-iissue 
cross-contamination into the equation model (15). The apical 
region of the left ventricle was excluded from quantification 
owing to out-of-plane partial volume effects, which cannot be 
corrected with the described correction method, Four sectors 
in each plane were assigned to each of the three major vascular 
territories (i.e., left anterior descending, left circumflex and 
right coronary artery territories) (14). The ROIs were then 
copied to the entire serially acquired N-13 ammonia image 
sequence, and regional myocardial tissue time-activity curves 
were obtained. in each vascular territory, a single time-activity 
curve was obtained by averaging the corresponding N-13 
ammonia data in adjacent ventricular planes. A small circular 
region (radius three pixels) was placed in the blood pool of the 
two most basilar left ventricular planes and copied to the entire 
serially acquired image sequence to obtain the arterial input 
function. The time-activity curves were then fitted with a 
previously validated three-compartment tracer kinetic model 
(7,16). Because myocardial blood flow at rest is related to the 
rate-pressure product (17), an index of cardiac work, rest flow 
values were normalized to the corresponding rate-pressut e 
product in each subjed by dividing the rest flow value by the 
rate-pressure product and multiplying the result by a linear 
factor of 8,000 for each subject. 
Statistical ana$sis. Data are presented as mean value i 
SD. Changes in heart rate, blood pressure, rate-pressure 
product, myocardial blood fiow and flow reserve within and 
between groups were compared with the two-sided paired or 
unpaired Student r test as appropriate. Regional differences in 
myczardiai blood flows obtained from all three vascular terri- 
tories were assessed using repeated measures analysis of 
variance. A p value <0.05 was used to define statistical 
significance. 
ResutCs 
Hemody~amic Endings. Table 1 summarizes the hemody- 
namic findings at rest and during pharmacologic vasodi!ation 
in the patients with Kawasaki disease and in the healthy young 
adult volunteers. At rest, systolic blood pressure and rate- 
pressure product were higher in the patients with Kawasaki 
disease than in the healthy adult volunteers. During hyper- 
emia, both groups demonstrated a significant increase in heart 
rate and rate-pressure product, whereas no significant change 
was observed in systolic, diastolic or mean aortic blood pres- 
sures. 
Changes in myocardiial blood Bows. At rest, myocardial 
blood ftows in the patients with Kawasaki disease were higher 
than in the healthy adult volunteers (97 i 15 vs. 74 t 
15 ml/iOfJ g per min, p < 0.05, Table 2). However, rest blood 
flows were similar in the two groups when they were normai- 
ized to the rate-pressure product (82 i 14 vs. 77 t 16 ml/100 g 
per min, p = NS, Table 2). 
During adenosine-induced vasodilarion, myocardial blood 
flows increased significantly in both the patients with Kawasaki 
disease (82 2 14 to 263 !I 64 ml/lo0 g per min, p < 0.01, Fig. 
1) and in the healthy adult volunteers (77 f 16 to 340 F 
57 mt/lOO g per min, p < 0.01, Fig. 1). HoNever, hyperemic 
blood flows were significantly lower in the patients with 
Kawasaki disease than in the control subjects (263 t 64 VS. 
340 rt 57 n1!,000 g per min. p = 0.01, Fig. I). The reductd 
hyperemic blood flows in the patients with Kawasaki disease, 
as sompared with the healthy young adult volunteers, resulted 
in a markedly lower myocardial flow reserve (3.2 + 0.7 vs. 
4h i 0.9, p = 0.003). 
“Minimal” coronary- resistance. To relate the hyperemic 
blood flow to one of its major determinants-the coronas 
perfusion pressure-the mean aortic blood pressure was di- 
vided by the hyperemic blood flow, and an index of the 
“‘minimal” coronary resistance ‘cyas obtained. At rest, corona? 
resistances were similar in both the patients with Kawasaki 
disease and healthy young adult volunteers (92 2 21 vs. 108 i: 
24 mm Hgimi per g per mini p = NS, Table 2). During 
hyperemia, coronary resistances decreased significantly in both 
the patients with Kawasaki disease (92 2 21 to 33 it 11 nun 
Hg/ml per g per min, p < 0.05, Table 2) and healthy young 
adult volunteers (108 i 24 to 24 -+ 5 mm I&/ml per g per min, 
p < 0.05, Table 2). However. minimal hyperemic coronary 
resistances remained higher in the patients with Kawasaki 
disease (33 + 11 vs. 24 rt 5 mm Hgiml per g per min, p = 0.04, 
Table 2). 
Regionali vari&iiity of nrymmlial pePfusion. None of the 
patients with Kawasaki disease had objective evidence of 
adenosine-induced regional perfusion abnormalities by quan- 
titative analysis of PET images, nor dlii they have ischemic 
ECG changes during adenosine infusion (Fig. 2). 
Quantitative measurements of blood flow demonstrated a 
Patients With Healthy 
Kawasaki Disease ‘tioung Adults 
(n = 10; in = IO) 
----.1_11 
.&$‘C,Gardidi blood f?W 
(miilO4 g per min) 
Rest 97 f 15.- 74 t 15 
Rest. corrected 82 I 14 77 I 16 
Adenosine 263 I &St -3Ot57 
M~ocardial flow reserve 3.2 z 0.7: 4.6 t 0.Y 
Minimal coronary 
resistance (mm Hgjmi 
per g per min) 
Rest Y2 2 21 10s z 24 
Adenosine 33 e :ig: 24 I 5 
--- 
*p i 0.095 versus heakh young adulrs. tp = 0.01 versus healthr~oung ad&. 
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Rest, corrected = corrected for rate-pressure product. 
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Figure I. Scatter plot of changes in myocardial blood fiow during 
adenosine infusion in the patients with Kawasaki dis-ase and healthy 
youirg adult control subjects, Normalized (to the rate-pressure prod- 
uct) rest blood flows were similar in both the patients with Kawasaki 
disease and healthy adult control subjects (82 Z!I 14 vs. 77 i 16 n@lOO g 
per min, p = NS). However, hyperemic hlnod illows in the patiems with 
Kt~wasalii d sease were significantly lovver than those in the healthy 
adult coned: subject!: (263 t 64 vs. 340 -i 57 ml/I00 g per min, p = 
0.01). 
similar regional variability in the patients wit11 Kawasaki 
disease and in the healthy adult volunteers at baseline (~coef- 
ficient of variation 8 I 4’i/o vs. 9 rfr S%, p = NS). After 
adcnosine infusion, regional blood flow measurements were 
more variable, although not statistically different, in the pa- 
tients with Kawasaki disease than in the healthy young adu!t 
volunteers (coefficient of variation 14 k 10% vs. 8 4 7% p = 
0.09). 
D’3emssisn 
The results of the preset study suggest, for the first time, 
that adenosine-induced blocic’ flows and myocardial flow re- 
serve may be globally impaired in children with a previous 
history of Kawasaki disease and normal epicardial coronary 
arteries. These findings agree with pathologic observations 
made during the acute stage of Kawasaki disease demonstrat- 
ing a diffuse coronary vasculitis. Further support for our 
findings is provided by a recent study by Suzuki et al. (lS), 
which demonstrates a modest increase in intimal thickness, 
as assessed by intravascular ultrasound, with impaired 
endothelium-dependent vasodilation in the angiographically 
normal coronary arteries of children with previous Kawasaki 
disease, 
The cause of the impaired hyperemic blood flows and flow 
reserve in the patients with Kawasaki disease is unknown. 
Because epicardial coronary lesions were not present in our 
patients with Kawasaki disease, the impaired blood flow re- 
sponse to coronary dilation may be attributed to obstruction in 
the small vessels resulting from fibrous thickening of the intima 
at the healed stage of Kawasaki d&case, which could not be 
visualized by echocardiography (19). The magnitude of blood 
flow response to adenosine-induced vasodilation depends, to a 
large extent, on the coronary perfusion Fressure. In this study, 
$%x-3493 
Figure 2. Positron emission tomographic (PET) and nitrogen-13 (N- 
131 ammonia images of the heari ia short-axis views obtained in 
corresponding icai, midventricular ami basai Ievelf at rest (top) and 
durirrg a&cosine stress testing (bottom) in a patient with a pr~esious 
history of Kawasaki disease. In the gray-sca!e coding, dark black 
represents the highest Rows and light gray the lowest. The images are 
oriented with the anterior watl on the tap, the intrmentricuiar septum 
to the ieft, the lateral wall to the: right and the inferior wall to the 
bottom. There was homogeneous distribution of N-E activity at rest 
and during adenosine strtiss lesiing in all icft vent&xix regions. The 
global quantitative myocsrdial blood flow by PET was S2 ml/IO0 g per 
min at rest and 263 ml/100 g per min durir?g hyperemia, with a How 
reserve of 3.23. 
we estimated the “minimal” coronary resistance to relate the 
hyperemic flows to the coronary perfusion pressure. Results of 
this normalization indicated that the hyperemic coronary re- 
sistances in the patients with Kawasaki disease were higher, 
although modestly, than those in the health:,~ yomtg adult 
volunteers (Table 2), suggesting an increased impedance to 
blood flow during coronary vasodilarion. A progressive in- 
crease in coronary resistance with increasing huuen narrowing 
has been demonstrated in previous studies of patients with 
atherosclerotic coronary artery disease (11,20). It does not 
seem likely that the impaired flow reserve in the patients with 
Kawasaki disease resulted from stenotic lesions in the large 
epicardial vessels, which went undetected by previous echocar- 
dtography. Transthoracic echocardiography is currently used in 
the acute phase of illness to detect coronary artery irwolvement 
in patients diagnosed with Kawasaki disease and has e~&nt 
sensitivity (197%) and specificity (>97% j (21,X). Fwther- 
more, Sugimura et al. (23) reported intimal abnormalities, as 
assessed by intracoronary ultrasound, in the epicardiai vessels 
of patients with Kawasaki disease only at the sltc of previous 
coronary aneurysms. In our study group, none of the patients 
with Kawasaki disease had a history of previous aneurysmal 
formation. 
Although hyperemic blood flows and flow reserve were, on 
average, significantly lower in the patients with Kawasaki 
disease (Table 2), our data show that the impailment in blood 
flows and flow reserve can vary appreciably between patients 
(Fig. 1). This may be related to physiologic variables, as well as 
to limitations in some of the methodologies applied in this 
study. There was also substantial variability in hyperemic blood 
flows among the healthy young adult volunteers, as in previous 
In this study, the : cst blood flows in the patients with 
Kawasaki disease wer,: higher than those obtained in the 
healthy young adult volunteers (Table 2). Myocardial blood 
flow at rest is closely related to oxygen demand, which in turn 
is related to cardiac work. Indeed, a close correlation behvecn 
myocardial blood flow at rest and the rate-pressure product 
has been previously demonstrated (17). Systolic Mood pressure 
(a determinant of oxygen demand) was higher, although only 
modestly, in the patients with Kawasaki disease than in tllc 
healthy young adult volunteers (Tabie I). The reason for and 
potential significance of this finding remain unknown All 
patient: with Kawasaki disease in this study had normal blood 
pressure during their cardiology clinic visits and had noi-ma1 
blood pressure response during maximai exercise testing. 
Therefore, to account for the increased cardiac work load? rcsb 
flow values were normalized to the rate-pressure product in 
each subject. This normalization resulted in similar rest flows 
in both groups (Table 2). 
Seven of 10 patients with Kawasaki disease in this study 
have been previously reported to have reversible perfusion 
abnormalities on SPECT imaging (3). In these patients, the 
SPECT defects were reported to be located in the anterior wall 
in two patients, in the lateral wall in three patients and in the 
inferior wall in the other two patients (3). In all these regions, 
hyperemic blood flows and flow reserve, as measured by PET. 
were lower in the patients with Kawasaki disease than in the 
control subjects. Furthermore, maxtmal tlov;s and flow reserve 
were also impaired in the apparently “normai” regions on 
SFECT. Therefore, our findings suggest thai rile patients with 
Kawasaki disease had global rather than regiona! abnormali- 
ties in myocardial perfusion. These findings agree with the 
theory that the vasculitis of Kawasaki disease is generally a 
diffuse process, as demonstrated by pathologic studies (19) and 
more recently by intravascular ultrasound (IS). The reason for 
the apparent discrepancy between the previously reparted 
SPECT defects and the present study remains unknown. 
Although it is possible that the regional abnormalities seen on 
the SPECT images of these patients may have resolved in the 
interval (>3 years have elapsed between the SPECT and PET 
evaluations), as discussed by the authors of the SPECT report 
(3), it is difficult to determine how the presence of i’alse 
Second, a method-related variability in OUT measurements 
of myocardial blood flow and flow reserve may have also 
influenced our findings. However, the approach used in this 
study yields reproducible measurements of blood flow, as 
demonstrated previously in patients with coronaoF artery dis- 
ease (31). Flow values at rest and during hyperemia in each 
major vascular territory differed randomly between the iwo 
measurements, with a correlatir~n coefiicient of 0.S 1 and 0.90, 
respectively, 
S9.x-l~ implisatin?K The l&dings of the present study hitve 
several implications. First, noninvasive q~~anti~catiun of myo- 
cardial blood flow using N-13 ammonia and PET imaging is 
feasible in the pediatric poputation. Second, our data suggest 
that hyperemic blocd flows in children with a history of 
Kawasaki disease are impaired, despite the absence of abnor- 
malities in the epicardial coronary arteries. Third3 blood flow 
abnormalities were global and not localized to a single vascular 
distribution, suggesting a diffuse rather than a regional reduc- 
tion in the dilator capacity of the m~crocircu!~ltion. 
Although flow estimates in the patkilts with Kawasaki 
disc&se were statistically ditferent (i.e.. lower) than those in the 
healthy young adulr volunteers, this may not nscessariiy have a 
direct clinical implication, at least during the childhood period, 
A myocardial flow reserve >3. as mensurcd in our patients 
with Kawasaki disease, correlates well with the fact that 
exercise pexfmnance in these patients is generally normai (3); 
thus, it seems reasonable to allow these children to perform 
tmrestricted exercise activities. However, we believe that our 
%x!!ir?f;s provide {mportant new information concerning the 
potentin”! late axts of Kawasaki disease on the coronal~ 
circulnlior:. To our knowledge this is the frrst study reporting 
su& a r&don. Further investigaJ.ion ix warrwted !o deter- 
r&c &ether a reduced vasodilator reserve may constitute a 
marker for latcs complications of Maws&i disease, or may 
affect the severity of flow abnormalities in the event of 
coro~wy arteq disease during adulthood. 
--- --*-“-. ___I- 
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